Metamizol Pensa

Metamizole magnesium, the active ingredient in Metamizol Pensa, is a pyrazolone analgesic presented as an oral formulation for systemic use. It is employed to relieve pain, reduce fever, and alleviate colic in adult patients.

GNH USA supplies Metamizol Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability, comprehensive regulatory support, and responsive technical assistance throughout the supply chain.

Metamizol Pensa, a pyrazolone analgesic, acts on inflammatory and pain pathways to provide symptomatic relief. - Pain: provides effective analgesia for acute, postoperative or trauma‑related pain, improving patient comfort. - Fever: produces antipyretic action that rapidly reduces high body temperature in infectious or inflammatory fevers. - Colic: eases severe visceral discomfort caused by gastrointestinal or biliary colic, facilitating symptom control.

Metamizole magnesium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Dizziness: transient light‑headedness. - Skin rash: mild erythematous reaction.

Serious or Rare Side Effects: - Agranulocytosis: severe neutropenia that can cause serious infections. - Stevens‑Johnson syndrome: rare severe skin reaction with blistering. - Anaphylaxis: acute allergic response that may be life‑threatening.

When prescribing Metamizol Pensa, several precautions should be observed to minimize risk. - Assess renal function: evaluate kidney status before initiating therapy. - Monitor blood counts: perform regular complete blood count to detect leukopenia. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use caution in elderly: start with lowest effective dose and monitor closely. - Limit concomitant myelosuppressive agents: avoid combining with drugs that suppress bone marrow. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Metamizol Pensa can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Concurrent myelosuppressive drugs: may increase risk of severe blood dyscrasias. - ACE inhibitors: combined use can potentiate hypotensive effects. - Anticoagulants: may enhance bleeding tendency.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce analgesic effectiveness of metamizole. - Alcohol: can increase central nervous system depression. - Cimetidine: may alter metabolism and increase plasma levels.